ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,304.72
0.70%
Dow Jones
39,069.59
0.01%
US Dollar vs MXN
16.6712
-0.11%
Brent Oil
82.085
0.13%
Bitcoin
69,103.82
0.87%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Reino Unido
  5. LSE
  6. Astrazeneca Plc (AZN)

  7. Astrazeneca Plc (AZN) Noticias

AZN

Astrazeneca (AZN)

Astrazeneca Plc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:LSE:AZN
FechaHoraFuenteTítuloSímboloCompañía
21/05/202406:18Alliance NewsAlliance NewsEXTRA: AstraZeneca pins hopes on pipeline as plans new era of growthLSE:AZNAstrazeneca Plc
21/05/202402:18Alliance NewsAlliance NewsTOP NEWS: AstraZeneca eyes new era of growth with bold new revenue aimLSE:AZNAstrazeneca Plc
21/05/202401:00RNS Regulatory NewsAstraZeneca PLC AstraZeneca to deliver $80bn revenue by 2030LSE:AZNAstrazeneca Plc
20/05/202402:24Alliance NewsAlliance NewsTOP NEWS: AstraZeneca plans to build manufacturing plant in SingaporeLSE:AZNAstrazeneca Plc
20/05/202401:00RNS Regulatory NewsAstraZeneca PLC AstraZeneca to manufacture ADCs in SingaporeLSE:AZNAstrazeneca Plc
16/05/202404:27Alliance NewsAlliance NewsAstraZeneca trials yield positive results for immunocompromised patientsLSE:AZNAstrazeneca Plc
16/05/202401:00RNS Regulatory NewsAstraZeneca PLC SUPERNOVA Trial Met COVID-19 prevention endpointLSE:AZNAstrazeneca Plc
15/05/202409:00RNS Regulatory NewsAstraZeneca PLC Director/PDMR ShareholdingLSE:AZNAstrazeneca Plc
08/05/202403:44Alliance NewsAlliance NewsAstraZeneca says withdraws Covid vaccine "for commercial reasons"LSE:AZNAstrazeneca Plc
07/05/202401:00RNS Regulatory NewsAstraZeneca PLC AstraZeneca completes Cellectis equity investmentLSE:AZNAstrazeneca Plc
06/05/202401:46Alliance NewsAlliance NewsAstraZeneca completes collaboration and investment deal with CellectisLSE:AZNAstrazeneca Plc
02/05/202404:04Alliance NewsAlliance NewsAstraZeneca notes positive trial results for Calquence treatmentLSE:AZNAstrazeneca Plc
02/05/202401:00RNS Regulatory NewsAstraZeneca PLC Calquence combination improved PFS in 1L MCLLSE:AZNAstrazeneca Plc
01/05/202409:00RNS Regulatory NewsAstraZeneca PLC Total Voting RightsLSE:AZNAstrazeneca Plc
29/04/202403:13Alliance NewsAlliance NewsAstraZeneca makes progress with Truqap and Enhertu cancer treatmentsLSE:AZNAstrazeneca Plc
29/04/202401:05RNS Regulatory NewsAstraZeneca PLC Truqap recommended for EU breast cancer approvalLSE:AZNAstrazeneca Plc
29/04/202401:00RNS Regulatory NewsAstraZeneca PLC Enhertu improved PFS in HER2-low and ultralowLSE:AZNAstrazeneca Plc
25/04/202407:00PR Newswire (US)AbelZeta Announces Abstract for C-CAR031 Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingLSE:AZNAstrazeneca Plc
25/04/202403:18Alliance NewsAlliance NewsTOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growthLSE:AZNAstrazeneca Plc
25/04/202401:00RNS Regulatory NewsAstraZeneca PLC 1st Quarter ResultsLSE:AZNAstrazeneca Plc
24/04/202404:32Alliance NewsAlliance NewsAngle shares jump on supplier agreement with with AstraZenecaLSE:AZNAstrazeneca Plc
16/04/202405:38Alliance NewsAlliance NewsIN THE KNOW: Deutsche ups AstraZeneca as higher payout addresses worryLSE:AZNAstrazeneca Plc
16/04/202402:39Alliance NewsAlliance NewsAstraZeneca's hails Imfinzi survival data on cancer formLSE:AZNAstrazeneca Plc
11/04/202411:42Alliance NewsAlliance News*AstraZeneca AGM resolutions pass, but 36% vote against remuneration policyLSE:AZNAstrazeneca Plc
11/04/202411:30RNS Regulatory NewsAstraZeneca PLC Result of AGMLSE:AZNAstrazeneca Plc
11/04/202402:56Alliance NewsAlliance NewsTOP NEWS: Astra plans 7% dividend hike for 2024 after no rise in 2023LSE:AZNAstrazeneca Plc
11/04/202401:00RNS Regulatory NewsAstraZeneca PLC AstraZeneca increases 2024 dividend by 7%LSE:AZNAstrazeneca Plc
08/04/202402:36Alliance NewsAlliance NewsTOP NEWS: AstraZeneca hails neurological data for Ultomiris, SolirisLSE:AZNAstrazeneca Plc
08/04/202401:00RNS Regulatory NewsAstraZeneca PLC Enhertu approved in US for HER2+ solid tumoursLSE:AZNAstrazeneca Plc
08/04/202400:53Alliance NewsAlliance NewsTOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approvalLSE:AZNAstrazeneca Plc
 Showing the most relevant articles for your search:LSE:AZN

Su Consulta Reciente

LSE
CTEA
Catenae Innovation
BOV
KIVO12
Fii Kivo Ci
AMEX
EMAN
eMagin
ASX
ZERNB
Zeta Resources
LSE
0QR0
Adval Tech
BIT
P84118
BNP Paribas Issuance
LSE
FIN
Finseta
EU
ALMOU
Moulinvest
LSE
ONC
Oncimmune
LSE
0ITP
Caisse Regionale De Cred...
AMEX
IIP
Internap
LSE
0RIV
Treasure Asa
NYSE
JMF
Nuveen Energy MLP Total ...
LSE
0KQK
Proshares Ultra Financials
NASDAQ
SINT
SiNtx Technologies
LSE
VTY
Vistry
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados